BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study

Authors

Sophie Dupuis‐Girod (ORCID: https://orcid.org/0000-0002-8834-5526)
Sophie Rivière
Ruben Hermann (ORCID: https://orcid.org/0000-0002-1920-6450)
A Guilhem (ORCID: https://orcid.org/0000-0003-4085-8784)
Évelyne Decullier (ORCID: https://orcid.org/0000-0002-2412-4767)
V. Leguy‐Seguin
Anne‐Emmanuelle Fargeton (ORCID: https://orcid.org/0000-0003-3085-9580)
Christian Lavigne (ORCID: https://orcid.org/0000-0002-2538-0076)
Vincent Grobost (ORCID: https://orcid.org/0009-0003-5352-7949)
Thierry Chinet (ORCID: https://orcid.org/0000-0001-8116-5816)
Hélène Maillard

Institutions

Université Claude Bernard Lyon 1 (FR)
Inserm (FR)
Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
Centre Hospitalier Universitaire de Lille (FR)
CEA Grenoble (FR)
Hôpital Femme Mère Enfant (FR)
Centre Hospitalier Universitaire de Montpellier (FR)
Assistance Publique – Hôpitaux de Paris (FR)
Hospices Civils de Lyon (FR)
Centre Hospitalier Universitaire d'Angers (FR)
Health Services and Performance Research Laboratory (FR)
Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
Hôpital Ambroise-Paré (FR)
Research on healthcare performance (FR)
Université Grenoble Alpes (FR)

Publication Details

Journal: Therapeutic Advances in Hematology
Published: 2025-04-14
DOI: https://doi.org/10.1177/20406207241300828
Citations: 2
Primary Topic: Vascular Anomalies and Treatments
Type: article
Field-Weighted Citation Impact: 3.25

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study

Sophie Dupuis‐Girod, Sophie Rivière, Ruben Hermann, A Guilhem et al.

Apr 14, 2025

2 citations

Therapeutic Advances in Hematology

Vascular Anomalies and Treatments

3.25

article

BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study

Sophie Dupuis‐Girod, Sophie Rivière, Ruben Hermann, A Guilhem, Évelyne Decullier, V. Leguy‐Seguin, Anne‐Emmanuelle Fargeton, Christian Lavigne, Vincent Grobost, Thierry Chinet, Hélène Maillard

April 14, 2025article en

2 citations

Abstract

No abstract available for this paper.

Therapeutic Advances in HematologyVol. 16

Université Claude Bernard Lyon 1 (FR), Inserm (FR), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Centre Hospitalier Universitaire de Lille (FR), CEA Grenoble (FR), Hôpital Femme Mère Enfant (FR), Centre Hospitalier Universitaire de Montpellier (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Centre Hospitalier Universitaire d'Angers (FR), Health Services and Performance Research Laboratory (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Hôpital Ambroise-Paré (FR), Research on healthcare performance (FR), Université Grenoble Alpes (FR)

Good health and well-being

Openalex Percentile: Top 9%

Vascular Anomalies and Treatments

3.25

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.